Category Archives: Spinal Cord Injury Treatment

InVivo Therapeutics Prices 8.2M Shares Offering

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted February 21, 2012 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , , , , | Comments Off

InVivo Therapeutics Announces Net $18.1M In Offering

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted February 21, 2012 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries, today announced the full exercise of the over-allotment option granted to the underwriters to purchase 1,242,236 additional shares, at a public offering price of $2.10 per share, in connection with its previously announced underwritten public offering of 8,281,574 shares, bringing aggregate gross proceeds from the offering to $20 million dollars. Net proceeds to InVivo, after deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $18.1 million. Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , | Comments Off

InVivo Therapeutics Announces Full Exercise of Over-Allotment Option

CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries, today announced the full exercise of the over-allotment option granted to the underwriters to purchase 1,242,236 additional shares, at a public offering price of $2.10 per share, in connection with its previously announced underwritten public offering of 8,281,574 shares, bringing aggregate gross proceeds from the offering to $20 million dollars Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , , , , | Comments Off

High Doses of Load Slows Bone Loss in Spinal Cord Injury

Newswise — Loss of bone density leads to brittle bones that fracture easily. It is a major complication of spinal cord injury (SCI), which affects about 250,000 Americans every year Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , | Comments Off

InVivo Therapeutics Announces Pricing of Public Offering of Common Stock

CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries, today announced the pricing of an underwritten public offering of 8,281,574 shares of its common stock, offered at a price to the public of $2.10 per share, for gross proceeds of approximately $17.4 million. Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , , , | Comments Off

High doses of 'load' slows loss of bone in spinal cord injury

A new clinical trial conducted by University of Iowa researchers shows that delivering high doses of “load,” or stress, to bone through programmed electrical stimulation of the muscle significantly slows the loss of bone density in patients with SCI. Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , , , | Comments Off

InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on Fox News First and San Antonio Living

CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on San Antonio’s Fox News First on KABB-TV on Wednesday, February 22nd during their 7:00 AM (CST) newscast. Reynolds is also scheduled to appear the same day on San Antonio Living on WOAI-TV that airs from 10:00 to 11:00 AM (CST). Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , | Comments Off

Chamber May Open Window for Treating Spine

Assessing and developing treatment for spinal cord injuries has long proved difficult for scientists hampered by a lack of available tools and imaging techniques. Now however, a team of Cornell researchers has developed a method to potentially circumvent this problem by surgically implanting a window into the spinal cord of a mouse, allowing for dynamic and long term imaging at a cellular level. In an article published in the January issue of Nature Methods, Prof. Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , , , , | Comments Off

Neuralstem Announces Closing of $5.2-Million Registered Direct Offering

ROCKVILLE, Md., Feb. 14, 2012 /PRNewswire/ — Neuralstem, Inc Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , , , , | Comments Off

Velomedix Receives IDE Approval to Evaluate the Use of Rapid Therapeutic Hypothermia in the Management of AMI Patients

MENLO PARK, Calif.–(BUSINESS WIRE)– Velomedix, Inc., a clinical stage medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to evaluate the use of rapid therapeutic hypothermia for the treatment of patients suffering an acute myocardial infarction (AMI or heart attack) Continue reading

Posted in Spinal Cord Injury Treatment | Tagged , , , , , , , , , | Comments Off